The global smart syringe market was valued at $5,737 million in 2017, and is estimated to garner $13,792 million by 2025
Smart Syringe Market by Product Type (Auto Disable, Active Safety, and Passive Safety), Application (Drug Delivery, Vaccination, and Blood Specimen Collection), Age Group (Pediatric and Adult), and End User, (Hospitals and HMOs, Diabetic Patients, Family Practices, and Psychiatrics): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
/EIN News/ -- New York, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Smart Syringe Market by Product Type, Application, Age Group, and End User,: Global Opportunity Analysis and Industry Forecast, 2018 - 2025" - https://www.reportlinker.com/p05663896/?utm_source=GNW
Smart Syringe Market Overview :
The global smart syringe market was valued at $5,737 million in 2017, and is estimated to garner $13,792 million by 2025, registering a CAGR of 10.3% during the forecast period. Smart syringes are designed with features to offer protection from needle stick injuries, blood-borne diseases such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), and life-threatening infections. They cater to several applications that include vaccination, drug delivery, and blood specimen collection. Smart syringes are of various types, which include auto disable (AD) syringes, passive safety syringes, and active safety syringes are used depending on the nature of application. Active safety syringes are the most common type of smart syringes used across all healthcare sectors, whereas, auto disable (AD) syringes are the most popular syringes used for vaccination purpose.
The industry is driven by increase in needle stick injuries, high prevalence of blood-borne transmission such as hepatitis B, C, HIV through improper injection practices, growth in adoption of safety syringes, and surge in technological advancements. In addition, the WHO mandate to switch to smart syringes to ensure safe injection practices is a major factor that boosts the growth of the market. However, high cost associated with smart syringes, especially passive safety syringes, low awareness in developing economies, and alternative drug delivery methods are expected to impede the market growth. The global smart syringes market volume is projected to reach 15.8 billion units by 2020 and is anticipated to grow at a CAGR of 8.2 during the forecast period.
The global smart syringe market is segmented based on product type, application, age group, end user, and region. Based on product type, the market is segmented into auto disable (AD) syringes, active safety syringes, and passive safety syringes. Based on application, the market is classified into drug delivery, vaccination, and blood specimen collection. Based on age group, the market is bifurcated into pediatric and adult. Based on end user, the market is categorized into hospitals and HMOs, diabetic patients, family practices, psychiatrics, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Market Benefits for Smart Syringe Market :
This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities.
Market estimations are based on a comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product type, application, age group, end user, and region.
In-depth analysis based on region helps understand the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
Smart Syringe Key Market Segments :
By Product Type
Auto disable syringes
Active safety syringes
Passive safety syringes
By Application
Drug delivery
Vaccination
Blood specimen collection
By Age Group
Pediatric
Adult
By End User
Hospitals and HMOs
Diabetic patients
Family practices (Physicians)
Psychiatrics
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY PLAYERS PROFILED
Welltok, Inc.
Intel Corporation
Nvidia Corporation
Google Inc.
IBM Corporation
Microsoft Corporation
General Vision, Inc.
Enlitic, Inc.
BioXcel Corporation
Berg Health
The other players of the smart syringe market include (companies not profiled in the report):
L.O.M. Medical International
Techcon, Tecan Trading AG
Meissner Filtration Products, Inc.
ARxIUM
Parker Hannifin Corporation
Read the full report: https://www.reportlinker.com/p05663896/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.